Analysis of metachronous colorectal neoplasms and survival following segmental or extended resection in patients with hereditary non-polyposis colorectal cancer
- 21 April 2020
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 35 (7) , 1273-1282
Abstract
Purpose The high incidence of metachronous colorectal tumours in patients with hereditary non-polyposis colorectal cancer (HNPCC) encourages extended resection (ER); however, the optimal surgical approach remains unclear. We evaluated the incidences of metachronous colorectal neoplasms following curative colorectal cancer segmental resection (SR) vs ER in patients with HNPCC and investigated patients’ oncologic outcomes according to surgical modality and mismatch repair status. Methods We retrospectively investigated medical records of patients with HNPCC (per the Amsterdam II criteria) treated for primary colon cancer at our institution between 2001 and 2017. All patients underwent intensive endoscopic surveillance. Results We included 87 patients (36 who underwent SR and 51 who underwent ER). The cumulative incidence of metachronous adenoma was higher in the SR group. One patient in the SR group (2.8%) and 3 in the ER group (5.9%) developed metachronous colon cancer; the difference was not significant (P = 0.693). Four patients in the SR group (11.1%) and 1 in the ER group (2.0%) developed distant recurrences; again, the difference was not significant (P = 0.155). Moreover, no significant differences were observed in the 5-year overall survival rates of patients in the SR and ER groups (88.2% vs 95.5%, P = 0.446); the same was true for 5-year disease-free survival rates (79.5% vs 91.0%, P = 0.147). Conclusion The incidence of metachronous cancer was not significantly different between the ER and SR groups; however, that of cumulative metachronous adenoma was higher in the SR group. Hence, intensive surveillance colonoscopy may be sufficient for patients with HNPCC after non-extensive colon resection.Keywords
Funding Information
- National Cancer Center (NCC-1810062, NCC-1610250)
This publication has 36 references indexed in Scilit:
- Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European expertsGut, 2013
- Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutationClinical Genetics, 2011
- Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgeryGut, 2010
- Risk of Colorectal Adenoma and Carcinoma After Colectomy for Colorectal Cancer in Patients Meeting Amsterdam CriteriaAnnals of Surgery, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramificationsClinical Genetics, 2009
- Missed Adenomas during Colonoscopic Surveillance in Individuals with Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)Cancer Prevention Research, 2008
- Segmental vs. Extended Colectomy: Measurable Differences in Morbidity, Function, and Quality of LifeDiseases of the Colon & Rectum, 2008
- Early Carcinogenic Events in HNPCC Adenomas: Differences with Sporadic AdenomasDigestive Diseases and Sciences, 2007
- Lower Incidence of Colorectal Cancer and Later Age of Disease Onset in 27 Families With Pathogenic MSH6 Germline Mutations Compared With Families With MLH1 or MSH2 Mutations: The German Hereditary Nonpolyposis Colorectal Cancer ConsortiumJournal of Clinical Oncology, 2004